ADRA1D anticorps (AA 286-335)

N° du produit ABIN6746725

Détail du produit anti-ADRA1D anticorps

Antigène: ADRA1D (Adrenergic Receptor, alpha 1d (ADRA1D))

Épitope: AA 286-335

Reactivité: Humain, Rat, Souris, Cheval, Chien, Lapin, Boeuf (Vache), Cobaye, Singe, Porc, Roussette (Chauve-souris)

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp ADRA1D est non-conjugé

Application: Western Blotting (WB)

Specificité: Human ADRA1D

Homologie: Percent identity by BLAST analysis: Human, Dog, Bovine, Rabbit, Pig, Guinea pig (100%) Sheep (92%) Mouse, Rat (85%).

Purification: Immunoaffinity purified

Immunogène: Synthetic peptide located between aa286-335 of human ADRA1D (P25100, NP_000669). Percent identity by BLAST analysis: Human, Gorilla, Monkey, Galago, Marmoset, Dog, Bovine, Bat, Rabbit, Horse, Pig, Guinea pig (100%), Sheep (92%), Mouse, Rat (85%).

Type of Immunogen: Synthetic peptide

Information d'application

Indications d'application: Approved: WB (0.2 - 1 μg/mL)

Usage: Western Blot: Suggested dilution at 1 μg/mL in 5 % skim milk / PBS buffer, and HRP conjugated anti-Rabbit IgG should be diluted in 1: 50,000 - 100,000 as secondary antibody.

Commentaires:

Target Species of Antibody: Human

Restrictions: For Research Use only

Stockage

Format: Lyophilized

Reconstitution: Distilled water

Concentration: Lot specific

Buffer: Lyophilized from PBS with 2 % sucrose

Conseil sur la manipulation: Avoid repeat freeze-thaw cycles.

Stock: 4 °C,-20 °C

Stockage commentaire: Long term: -20°C, the use of 50% glycerol is recommended if storing aliquots in -20°C for long term use (up to 1 year)
Short term (less than 1 week): 4°C. Avoid freeze-thaw cycles.

Références pour anticorps anti-ADRA1D (ABIN6746725)

Mirski, Gerlach, Cole: "Sequence determinants of nuclear localization in the alpha and beta isoforms of human topoisomerase II." dans: Experimental cell research, Vol. 251, Issue 2, pp. 329-39, (1999) (PubMed).

Brown, Holden, Rahn, Perkins: "Immunohistochemical staining for DNA topoisomerase IIa in Hodgkin's disease." dans: American journal of clinical pathology, Vol. 109, Issue 1, pp. 39-44, (1998) (PubMed).

Herzog, Holmes, Tuschong, Ganapathi, Zwelling: "Absence of topoisomerase IIbeta in an amsacrine-resistant human leukemia cell line with mutant topoisomerase IIalpha." dans: Cancer research, Vol. 58, Issue 23, pp. 5298-300, (1998) (PubMed).

Détails sur ADRA1D

Antigène: ADRA1D (Adrenergic Receptor, alpha 1d (ADRA1D))

Autre désignation: ADRA1D (ADRA1D Produits)

Synonymes: anticorps Adra-1, anticorps Adra1, anticorps Adra1a, anticorps Gpcr8, anticorps Spr8, anticorps [a]1d, anticorps alpha1D-AR, anticorps Adrd1, anticorps ADRA1, anticorps ADRA1A, anticorps ADRA1R, anticorps ALPHA1, anticorps DAR, anticorps dJ779E11.2, anticorps adrenergic receptor, alpha 1d, anticorps adrenoceptor alpha 1D, anticorps Adra1d, anticorps ADRA1D

Sujet: Name/Gene ID: ADRA1D
Subfamily: Adrenergic
Family: GPCR

Synonyms: ADRA1D, Alpha 1d, Alpha-1D adrenergic receptor, ADRA1R, Alpha-1D adrenoceptor, Alpha-1D adrenoreceptor, ALPHA1, Alpha-1D-adrenergic receptor, Alpha-adrenergic receptor 1a, Alpha1delta-AR, DAR, ADRA1, Adrenoceptor alpha 1D, Alpha-1A adrenergic receptor, DJ779E11.2

ID gène: 146

NCBI Accession: NP_000669

UniProt: P25100